Digital Diagnostics Closes $75M Series B Funding
Summary
Digital Diagnostics (formerly known as IDx), a Coralville, IA-based artificial intelligence diagnostic health care technology company, raised $75M in Series B funding. Ali Satvat, Partner and Global Head of Health Care Strategic Growth at KKR and Stephen Weiss, Managing Director of Cedar Pine, have joined the company’s board of directors. The company intends to use the funds to accelerate its product roadmap, expand its distribution footprint, and invest in sales and marketing. Led by CEO John Bertrand, Seth Rainford, co-founder, president, and COO, and Dr. Michael D. Abramoff, MD, PhD, founder and executive chairman, Digital Diagnostics is an AI diagnostics company on a mission to transform the quality, accessibility, equity, and affordability of global health care through the application of technology in the medical diagnosis and treatment process. Its flagship product, IDx-DR, is an FDA De Novo cleared autonomous AI diagnostic system designed to detect diabetic retinopathy (including diabetic macular edema) at the point-of-care.